- Home
- ATAT vs PRGO Comparison
ATAT vs PRGO Comparison
Compare ATAT & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATAT
- PRGO
- Stock Information
- Founded
- ATAT 2013
- PRGO 1887
- Country
- ATAT China
- PRGO Ireland
- Employees
- ATAT N/A
- PRGO N/A
- Industry
- ATAT Hotels/Resorts
- PRGO Biotechnology: Pharmaceutical Preparations
- Sector
- ATAT Consumer Discretionary
- PRGO Health Care
- Exchange
- ATAT Nasdaq
- PRGO Nasdaq
- Market Cap
- ATAT 3.3B
- PRGO 3.5B
- IPO Year
- ATAT 2022
- PRGO 1991
- Fundamental
- Price
- ATAT $31.31
- PRGO $26.77
- Analyst Decision
- ATAT Strong Buy
- PRGO Buy
- Analyst Count
- ATAT 2
- PRGO 3
- Target Price
- ATAT $37.40
- PRGO $33.00
- AVG Volume (30 Days)
- ATAT 1.6M
- PRGO 1.5M
- Earning Date
- ATAT 05-22-2025
- PRGO 05-07-2025
- Dividend Yield
- ATAT 4.12%
- PRGO 4.33%
- EPS Growth
- ATAT 28.10
- PRGO N/A
- EPS
- ATAT 1.25
- PRGO N/A
- Revenue
- ATAT $1,059,112,934.00
- PRGO $4,335,200,000.00
- Revenue This Year
- ATAT $28.09
- PRGO $3.19
- Revenue Next Year
- ATAT $22.22
- PRGO $2.26
- P/E Ratio
- ATAT $25.09
- PRGO N/A
- Revenue Growth
- ATAT 43.38
- PRGO N/A
- 52 Week Low
- ATAT $15.22
- PRGO $23.14
- 52 Week High
- ATAT $34.23
- PRGO $30.93
- Technical
- Relative Strength Index (RSI)
- ATAT 61.84
- PRGO 52.70
- Support Level
- ATAT $30.70
- PRGO $26.19
- Resistance Level
- ATAT $32.16
- PRGO $27.40
- Average True Range (ATR)
- ATAT 1.19
- PRGO 0.57
- MACD
- ATAT 0.15
- PRGO 0.03
- Stochastic Oscillator
- ATAT 45.22
- PRGO 45.93
About ATAT Atour Lifestyle Holdings Limited
Atour Lifestyle Holdings Ltd is an upper-midscale hotel chain in China. The company derives revenues from franchise and management fees from its manachised hotels and sales of hotel supplies to manachised hotels, Operations of leased hotels, and sales of retail products. The company has one operating segment, which is the Atour Group.
About PRGO Perrigo Company plc
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.